The total number of scientific publications in drug discovery in Japan shows a declining trend from 2024 to 2028, with values dropping from 304.03 research papers in 2024 to 275.28 in 2028. The year-on-year percentage decrease suggests a consistent reduction in output, reflecting potential shifts in research focus, funding allocation, or collaborative efforts. The compound annual growth rate (CAGR) over this period supports an average annual decline.
Future trends to watch include:
- Impact of global collaborations and partnerships in enhancing research opportunities.
- Government and private sector investment in research and development.
- Adoption of advanced technologies such as AI and machine learning in drug discovery.
